Can Mounjaro Give You Hives — and What Should You Do?

Step 1, Work out where the reaction is and what it looks like

The first thing worth doing is locating the reaction precisely. Mounjaro is injected under the skin (abdomen, thigh or upper arm) and the most common skin-level side effect is a local reaction at that injection site: a small patch of redness, some firmness, mild swelling or itching directly where the needle went in. This is the body responding to the mechanical event of the injection and to the medicine itself entering local tissue. These localised reactions tend to peak within an hour or two and fade within a day. They're noted in the NHS's patient information for tirzepatide and are generally not a reason to stop treatment.

Hives are different. They appear as raised, pinkish or red welts that can emerge anywhere on the body, often itch intensely, and may move around, a patch fading on one arm while another appears on the torso. Unlike a fixed injection-site mark, generalised hives suggest the immune system is reacting to the medicine systemically. They are uncommon, but they are documented in the Mounjaro SmPC and need to be taken seriously, and if you want a detailed explanation of why this happens, the page covering whether Mounjaro can cause hives walks through the mechanisms and what to watch for. Rotating your injection sites as your prescriber recommends can reduce local reactions; it won't prevent a systemic skin response if one is going to occur.

A useful first step is to check whether any other potential trigger is present: a new food, a new laundry product, a seasonal allergen. That doesn't mean dismissing the Mounjaro connection, it means gathering information your prescriber will ask about.

Step 2, Assess whether any red-flag signs are present

This step is the most clinically important one, and it's worth being direct about it. Hives that appear alongside any of the following require a 999 call or an immediate trip to A&E, do not wait to see if they resolve:

Swelling of the face, lips, tongue or throat. A sensation of throat tightening or difficulty swallowing. Sudden breathlessness or wheezing. Feeling faint or dizzy. A rapid heartbeat accompanying the skin changes.

These are the signs of anaphylaxis, a severe allergic reaction. Anaphylaxis is rare with Mounjaro, but it is a known possibility with injectable medicines as a class, and the Mounjaro SmPC advises stopping treatment and seeking urgent help if a serious allergic reaction is suspected. The MHRA's Yellow Card scheme allows patients and healthcare professionals to report serious reactions, doing so helps build the safety picture for everyone using the medicine.

If none of those red-flag signs are present and you have hives that are itchy but otherwise stable, you are not in immediate danger. You should still contact your prescriber or GP the same day rather than waiting for a routine appointment.

Step 3, Tell your prescriber and keep a record

Once you've ruled out an emergency, contact whoever is managing your Mounjaro treatment. A prescriber needs to know about any new skin reaction, not to alarm you, but because the pattern of the reaction helps them advise you correctly. They'll want to know: when the hives appeared relative to your last injection, how long they lasted, where on the body they were, and whether you took anything (such as an antihistamine) that helped.

In most cases of mild, isolated hives without any accompanying systemic symptoms, a prescriber can assess whether the reaction is likely to be dose-related, whether antihistamine cover is appropriate, or whether the treatment should be paused. Stopping Mounjaro without clinical guidance is not always necessary, but continuing without telling anyone is also not advisable. Your prescriber is the right person to make that call.

If you started Mounjaro privately, including through an online service, your aftercare channel matters here. At nume, prescriber support is available seven days a week precisely for situations like this, a skin reaction you're not sure how to read is exactly the kind of clinical query that shouldn't wait until Monday.

Step 4, Context: how often does this actually happen?

Mounjaro's full prescribing information categorises hypersensitivity reactions (which include hives, rash and angio-oedema) as uncommon, meaning they affect fewer than 1 in 100 people. Injection-site reactions are classified as common. To understand the full side-effect profile and how Mounjaro was assessed across its clinical programme, NICE's appraisal of tirzepatide (TA1026) provides the regulatory overview.

If you're curious about how skin-related side effects compare to the gastrointestinal ones that most people talk about (nausea, loose stools, reflux) there's more detail on the Mounjaro and hives page, and a broader look at stomach-related effects on the Mounjaro and gas page. For those considering whether Mounjaro is right for them in the first place, the Mounjaro overview covers eligibility and the consultation process. Cost is occasionally a factor in people's decisions about where to seek care; the context around Mounjaro's UK pricing is worth reading before drawing conclusions about what private treatment involves.

Skin reactions are one reason why Mounjaro is only prescribed after a proper clinical assessment, and why aftercare matters as much as the initial prescription. If you'd like a prescriber to review your situation, you can speak to our prescribers through a free consultation.